Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report) was the recipient of a large growth in short interest in October. As of October 30th, there was short interest totaling 94,671 shares, a growth of 82.8% from the October 15th total of 51,800 shares. Based on an average trading volume of 152,023 shares, the days-to-cover ratio is presently 0.6 days. Currently, 4.3% of the company’s stock are short sold.
Analyst Ratings Changes
TNON has been the topic of several research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tenon Medical in a report on Thursday, October 15th. Wall Street Zen downgraded Tenon Medical from a “hold” rating to a “sell” rating in a report on Saturday, October 31st. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold”.
View Our Latest Analysis on TNON
Tenon Medical Price Performance
Shares of TNON stock traded down $0.38 during trading hours on Friday, hitting $1.41. The stock had a trading volume of 184,179 shares, compared to its average volume of 129,033. The firm has a market capitalization of $3.79 million, a PE ratio of -0.04 and a beta of 1.43. The stock’s 50 day moving average is $3.00 and its 200 day moving average is $15.57. Tenon Medical has a twelve month low of $1.38 and a twelve month high of $43.05.
Tenon Medical (NASDAQ:TNON – Get Free Report) last announced its earnings results on Thursday, November 12th. The company reported ($5.39) EPS for the quarter, missing analysts’ consensus estimates of ($4.22) by ($1.17). Tenon Medical had a negative net margin of 305.10% and a negative return on equity of 907.60%. The business had revenue of $1.43 million during the quarter, compared to analyst estimates of $1.55 million.
Insiders Place Their Bets
In related news, major shareholder Financial Lp Hrt sold 65,582 shares of the business’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $5.56, for a total value of $364,635.92. Following the completion of the sale, the insider directly owned 15,839 shares of the company’s stock, valued at $88,064.84. The trade was a 80.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders have acquired 129,945 shares of company stock valued at $500,468 and have sold 136,599 shares valued at $605,467. 17.71% of the stock is currently owned by company insiders.
Tenon Medical Company Profile
Tenon Medical, Inc. (NASDAQ:TNON) is a medical device company focused on developing and commercializing technologies for the treatment of sacroiliac (SI) joint dysfunction. The SI joint connects the lower spine to the pelvis and can be a source of chronic lower-back and pelvic pain. The company’s primary product is the Catamaran SIJ Fusion System, a minimally invasive surgical system designed to stabilize and fuse the SI joint through a transfixation approach. The system uses a specialized implant and delivery instruments intended to support placement across the SI joint while addressing the underlying source of instability.
See Also
- Five stocks we like better than Tenon Medical
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
